Novoprotein Scientific Inc. (SHA:688137)

Market Cap	2.46B +0.2%
Revenue (ttm)	150.24M +11.4%
Net Income	-76.58M
EPS	-1.09
Shares Out	69.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,437,410
Open	34.92
Previous Close	35.34
Day's Range	34.92 - 37.97
52-Week Range	33.50 - 54.56
Beta	1.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 556
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688137

Financial Performance

In 2025, Novoprotein Scientific's revenue was 146.44 million, an increase of 14.80% compared to the previous year's 127.56 million. Losses were -77.78 million, 42.9% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 23, 2026

Data Sources Report a data error